StockWatch
·

BAFNA PHARMACEUTICALS LTD. Q3 FY25 Results

BAFNAPHQ3 FY25 Results
Filing
MetricValue (₹ Cr)vs Q2 FY25
Revenue33.1917.7%
Total Income33.3819.3%
Expenditure32.4216.3%
PBT0.9563.8%
Net Profit0.9563.8%
OPM-4.62%3.12pp
NPM2.84%3.49pp
EPS0.4064.0%
View full financials

Informational and educational content only. Not investment advice.